Long term cost-effectiveness analysis of IDegLira in the treatment of type 2 diabetes patients compared to GLP-1RA added to basal insulin after IDegLira entered the national reimbursement drug list in China

• Dunming Xiao,

  Roles Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Resources, Software, Validation, Visualization, Writing – original draft

  Affiliations School of Public Health, Fudan University, Shanghai, China, NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China

  ⨯
• Junling Weng,

  Roles Data curation, Formal analysis, Resources

  Affiliations School of Public Health, Fudan University, Shanghai, China, NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China

  ⨯
• Lei Zhang,

  Roles Funding acquisition, Writing – review & editing

  Affiliation Novo Nordisk (Shanghai) Pharmaceutical Trading Co., Ltd, Shanghai, China

  ⨯
• Chang Xing,

  Roles Funding acquisition, Writing – review & editing

  Affiliation Novo Nordisk (China) Pharmaceuticals Co., Ltd, Beijing, China

  ⨯
• Yan Wei ,

  Roles Conceptualization, Project administration, Writing – review & editing

  * E-mail: yanwei@fudan.edu.cn (YW); yychen@shmu.edu.cn (YC)

  Affiliations School of Public Health, Fudan University, Shanghai, China, NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China

  ⨯
• Yingyao Chen

  Roles Conceptualization, Methodology, Project administration, Supervision, Writing – review & editing

  * E-mail: yanwei@fudan.edu.cn (YW); yychen@shmu.edu.cn (YC)

  Affiliations School of Public Health, Fudan University, Shanghai, China, NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China

  https://orcid.org/0000-0002-3470-0748

  ⨯